Chemours Co (The) (CC)

MATERIALS: CHEMICALS
SIC: CHEMICALS & ALLIED PRODUCTS

1007 MARKET STREET WILMINGTON, DE 19801

Chemours Company manufactures and distributes performance chemicals. The Company produces titanium dioxide, refrigerants and industrial fluoropolymer resins, and industrial and specialty chemicals for gold producing, oil refining, agriculture, and other industries.

Data as of 2020-07-04
Market Cap2.573 Billion Shares Outstanding164.218 Million Avg 30-day Volume2.007 Million
P/E Ratio Dividend Yield6.382 EPS-0.26
Price/Sales0.636 Price cash flow ratio3.2 Price free cash flow ratio8.8
Book Value3.99 Price to Tangible Book3.61 Alpha0.01
Short Interest Ratio6.89 % Short Interest to Float8.3 R-squared0.301449
BETA2.43248 52-week High/Low21.71 / 7.02 Stddev0.188667
View SEC Filings from CC instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 4 3 (0.2%)
13F Filers holding this stock: 395 81 (5.3%)
Aggregate 13F shares on 03/31/2020: 130.914 Million 81.665 Million
Aggregate 13F shares on 12/31/2019: 132.78 Million 73.16 Million
Percent change: -1.41% 11.63%
Funds creating new positions: 65 21
Funds Adding to an existing position: 117 28
Funds closing out their position: 76 26
Funds reducing their position: 118 22
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANASTASIO CURT

  • Director
73,833 2020-07-05 2

BELL BRADLEY J

  • Director
68,981 2020-06-30 6

BROWN RICHARD H

  • Director
104,637 2020-06-30 6

CRANSTON MARY B

  • Director
0 2020-06-29 2

KEOHANE SEAN D PRESIDENT AND CEO

  • Officer
  • Director
0 2020-06-12 1

KELLIHER SUSAN M. SVP, PEOPLE & HEALTH SERVICES

  • Officer
12,872 2020-06-01 3

NEWLIN STEPHEN D

  • Director
20,980 2020-05-15 0

NEWMAN MARK

  • Director
18,079 2020-05-14 4

CRAWFORD CURTIS J

  • Director
0 2020-05-12 1

ALBRIGHT ELIZABETH

  • Director
5,363 2020-05-05 0

FARRELL DAWN L

  • Director
47,906 2020-04-28 1

KANE ERIN N

  • Director
20,859 2020-04-28 2

SNELL E BRYAN PRESIDENT, TITANIUM TECH

  • Officer
141,891 2020-03-13 4

VERGNANO MARK P

  • Director
22,766 2020-03-04 3

PARKER ERICH SVP CORP COMMUNICATIONS & CBO

  • Officer
0 2020-03-02 2

SHELTON DAVID C SVP, GC & CORP. SECRETARY

  • Officer
0 2020-03-02 3

SPARKS EDWIN C PRESIDENT, FLUORO & CHEM SOL

  • Officer
42,940 2020-03-02 2

RALHAN SAMEER SVP, CFO & TREASURER

  • Officer
0 2020-03-02 2

ABBOTT MATTHEW S VP, CAO & CONTROLLER

  • Officer
21,843 2020-03-02 3

TROJANOWSKI AMY VP AND CONTROLLER

  • Officer
45,746 2019-03-13 0

KIRSCH PAUL PRESIDENT - FLUOROPRODUCTS

  • Officer
0 2019-03-05 0

SIEMER CHRISTIAN W PRESIDENT, CHEMICAL SOLUTIONS

  • Officer
84,901 2018-02-04 0

VANLANCKER THIERRY FJ PRESIDENT - FLUOROPRODUCTS

  • Officer
0 2016-03-01 0

DUPONT E I DE NEMOURS & CO

  • 10% Owner
No longer subject to file 2015-07-01 0

ZELAC STEVEN VICE PRESIDENT

  • Officer
  • Director
0 2015-06-17 0

POND NIGEL VP & ASST. TREASURER

  • Officer
  • Director
0 2015-06-17 0

HEFFERNAN MICHAEL P. PRESIDENT

  • Officer
  • Director
0 2015-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BELL BRADLEY J - Director

2020-06-30 A 977 $15.35 a 8,589 68,981.47 direct

BROWN RICHARD H - Director

2020-06-30 A 1,779 $15.35 a 34,991 104,636.58 direct

KELLIHER SUSAN M. - Officer SVP, PEOPLE & HEALTH SERVICES

2020-06-01 F 289 $13.57 d 12,872 12,872.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments